Bioretec Ltd Company announcement 15 August 2024 at 8:00 a.m. TAMPERE, Finland, Aug. 15, 2024 /PRNewswire/ — This announcement is a summary of Bioretec Ltd’s half-year report January-June 2024. The complete half-year report with tables is attached to this release as a pdf file and available at the company’s web pages at https://bioretec.com/investors/investors-in-english/releases. April-June 2024 in brief Net sales increased by 68% and amounted to EUR 1,379 thousand (4-6/2023: EUR 820 thousand). Sales margin (excl. other income) was EUR 1,033 (609) thousand, or 74.9% (74.3%) of net sales. Profit (loss) for the reporting period was EUR -787 (-1,518) thousand. The comparison period included the cost of financing arrangement amounting to EUR 795 thousand. January-June 2024 in brief Net sales amounted to EUR 2,061 thousand (1-6/2023: EUR 1,891 thousand). Sales margin (excl. other income) was EUR 1,451 (1,327) thousand or 70.4% (70.2%) of net sales. The sales margin in January-June 2024 includes other income of EUR 72 (0) thousand accrued relating to a Business Finland grant. Profit (loss) for the reporting period was EUR -1,884 (-2,075) thousand. Earnings per share (undiluted) were EUR -0.09 (-0.11). Key figures EUR 1,000 4-6/2024 4-6/2023 Change, % 1-6/2024 1-6/2023 Change, % 1-12/2023 Net sales 1,379 820 68.3 % 2,061 1,891 9.0 % 3,906 Sales margin 1,045 609 71.6 % 1,523 1,327 14.8 % 2,810 Sales margin (excl. other income) 1,033 609 69.8 % 1,451 1,327 9.4 % 2,728 Sales margin, % of net sales 75.7 74.3 73.9 % 70.2 % 71.9 % Sales margin% (excl. other income) 74.9 74.3 70.4 % 70.2 % 69.8 % EBITDA -752 -639 17.8 % -1,864 -1,130 65.0 % -2,833 EBIT -782 -690 13.4 % -1,921 -1,233 55.8 %
Bioretec Ltd’s half-year report January-June 2024: RemeOs™ trauma screw controlled launch in the U.S. yielded expected positive clinical results
Read More
Additional Prop Firms
Established in 2022, LeseUp Trading is a proprietary trading firm already starting to revolutionise the landscape for aspiring traders.
Purdia Capital have set out to revolutionise the world of online funding, bridging the gap between online funding bodies and real proprietary trading firms.
FlexyTrade is a new prop firm in the futures prop trading industry. Established in March 2024 and based in Sheridan, Wyoming, FlexyTrade has come to life at a time when the futures funding industry is booming and many prop firms are being founded.
Phoenix Trader Funding offers enticing features for aspiring traders, including adaptable account sizes, scaling plans, and a free trial. Their fixed drawdowns and daily transparency measures instill confidence in risk management.
NexGen Futures Trader is a new player in the proprietary trading space. Built by traders, for traders, NexGen Futures Trader empowers aspiring funded traders with a unique platform to participate in the rewarding world of futures trading.
Leeloo's Performance Based Trading and Contest, offer the potential for payouts. With an industry-leading education platform, Leeloo attracts retail traders worldwide with its sterling reputation and commitment to the welfare of its traders.
They use an efficient assessment procedure to identify which traders they will provide with a funded trading account, with capital ranging from $25,000 to $250,000.
BluSky Trading Company’s impressive performance has attracted increasing attention to the proprietary trading firm, with ever more traders recommending its funded futures program as one of the best on offer in the industry.